Digg It
#1 in Business Subscribe Email Print

You are here: Home > Finance > Finance > FInancial Transactions

Tags

  • allowing
  • savers
  • product
  • combination products
  • their asset

  • Links

  • Internet Presence - First Page Of Google In Under 30 Days
  • Solar Energy Systems
  • Always Be Aware of Current Rates
  • Digg It - FInancial Transactions

    This article will study thoroughly the reimbursement that banks may convey to those who undertakes financial transactions and will research exclusively at the function of banks as financial intermediaries. These mediators assemble borrowers and lenders, dropping the expenses that would be applied when copi
    According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
    ng with each other in a straight line. They also assist them to trounce asymmetric information flows and permit borrowers with less effort access to funds for a lengthy time frame, at tolerable rates of interest, while allowing lenders to increase a return on their surplus of funds at a minor risk.

    Financ
    ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

    Examples of combination products may in
    ial intermediaries also utilise society’s scarce resources to increase productive efficiency and to raise the standard of living by allowing borrowers to invest today. The essay will also look at the issues of Maturity transformation, Risk transformation, Reduction of transaction costs, and Collection and
    lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

    Parcelling as each of these create benefits to those undertaking financial transactions.

    A very basic description of a financial system is a system which consists 'of a set of markets, and individuals and organisations that trade in those markets. The end users of the system are people and firms whose des
    here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
    re is to lend and to borrow.' Therefore a financial system is a form of intermediary bringing together potential borrowers and potential lenders.

    Potential borrowers and lenders have three options to choose from in order to get what they want, i.e. assets for lenders, such as a bank deposit, and liabiliti
    d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

    Combination pro
    es for borrowers, such as loans. The first option is to deal with one another directly, however this choice is very costly as it would be hard to find someone willing to lend money to a complete stranger, for example ?10,000, as this is very risky. The lender would have to put great trust in that person t
    ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
    o repay the full amount to them, or charge such a high interest rate to cover any potential damage that it would probably be unacceptable to the borrower. Also the fact that the lender has to promise to lend the money for a specific period of time and is unable to liquidate the asset, if the money is neede
    easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
    d, creates a great risk. This option is the least likely of the three, as there is too much risk involved and is too expensive for both parties.

    The second option is that a lender is able to purchase an existing asset from another lender, in a way this is refinancing the loan, an example of this is the st
    nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
    ck market.

    The third option is to deal with one another through a financial intermediary such as a bank as this limits risk, and costs. Intermediaries do much more than just bring borrowers and lenders together, as merely matching the needs of the borrowers and of the lenders from lists, then charging the
    and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
    m a fee for the introduction, is actually Brokerage. The job of financial intermediaries is 'to create assets for savers and liabilities for borrowers which are more attractive to each than would be the case if the parties had to deal with each other directly.'

    Intermediaries such as banks are deposit-tak
    ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
    ing institutions; these deposits are liabilities to the bank and assets to the lenders (savers). This deposit can be withdrawn with little or no notice, and can be considered as part of the national money supply. The bank issues loans to potential borrowers, which creates an asset for the bank and a liabi
    ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

    Following aspects would a
    lity for the borrower. As they are a profit maximising institution, it can be assumed that it will charge a higher rate of interest on the loans than the rate of interest given on the savers asset. Both the lenders asset and the borrower’s liability will remain on the intermediary's balance sheet until th
    dd to the challenges in developing combination products:

    Which markets to tap where the combination products can do fairly well?
    Which combination prod
    debt is paid off, or the lender withdraws their money.

    Due to the work of financial intermediaries there are many more financial assets and liabilities in existence than would be possible if borrowers and lenders were left to deal directly with one another. This is due to many reasons as there are many b
    cts are meaningful and rational?
    Which therapeutic categories to select?
    Which Combinations can address unmet needs of the patients?
    Do combin
    enefits for both the borrower and the lender when using intermediaries such as banks.

    There is less risk for the lender as their asset has liquidity; this is because financial intermediaries must enable the lender to access their money quicker than would be possible if they had deal directly with a borrowe
    tions increase the patient compliance?
    What would be the developing cost?
    How to tackle the risks encountered during combination product developmen
    r. Liquidity has three main aspects the first being the time it takes for the lender to retrieve their money. The second is the risk involved, financial intermediaries use Risk pooling, they hold the risk of the loan for the lender and only in extreme circumstances will their asset depreciate or not be re
    t?

    As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
    turned. Finally, the costs involved, if a sacrifice has to be made in order to retrieve the exchange of asset to money.

    The borrower also gains benefits from using an intermediary such as a bank, as it is much easier than dealing directly with the lender. They do not have to search for a compatible lende
    ping new procedures for reviewing their safety, efficacy and quality.

    Professional from academic institutions, pharmaceutical industries, health care indust
    and then sit negotiating interest rates etc. It is also much more cost effective as interest rates are lower due to the lowered risk of the lenders. However financial intermediaries must make loans available for extended amounts of time, for example twenty years, for borrowers while allowing lenders to w
    y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
    ithdraw their deposits with little, or no, notice. These contrasting needs would appear to cause a problem, as how could a bank pay off (lender) liabilities and still afford to maintain the assets (borrowers). The answer to this is that they create liquidity in four ways, through Maturity transformation,
    .

    As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
    Risk transformation, Reduction of transaction costs, and through Collection and Parcelling.

    Maturity transformation is where financial institutions use short-term liabilities to finance long-term assets. It can do this due to economies of scale, as it knows through experience that while deposits are being
    elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

    Companies that provide selfless information through particip
    withdrawn other new deposits are being made and therefore it only needs a sufficient amount of liquidity to meet the small amount of overall withdrawals. Banks due to large numbers of depositors are able to carry out maturity transformation and can also use this experience to implement risk transformation


    tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

    HTTP = HTML link (for blogs, profiles,phorums):
    <a href="http://www.diggit.org.ua/article/89947/diggit-FInancial-Transactions.html">FInancial Transactions</a>

    BB link (for phorums):
    [url=http://www.diggit.org.ua/article/89947/diggit-FInancial-Transactions.html]FInancial Transactions[/url]

    Related Articles:

    Tips for Starting A Small Business, Part I

    Six Power Tips on Resell Rights

    Seven Website Design Tips To Make Your Site More Attractive

    Bookmark it: del.icio.us digg.com reddit.com netvouz.com google.com yahoo.com technorati.com furl.net bloglines.com socialdust.com ma.gnolia.com newsvine.com slashdot.org simpy.com shadows.com blinklist.com